Center for Molecular Innovation and Drug Discovery

Design. Create. Innovate.

LEADERSHIP

Director

Karl A. Scheidt, Ph.D., Dow Chemical Company Research Professor of Chemistry, Weinberg College of Arts and Sciences, and Professor in Pharmacology

Professor Scheidt is a synthetic organic chemist whose research focuses on the development of new catalytic reactions and the total synthesis of molecules with important biological and structural attributes.

Advisory Board Members

The Center is guided by an advisory board composed of clinician and faculty leaders in the areas of biology, structural biology and chemistry.

Alfred George, Jr. M.D., Magerstadt Professor of Pharmacology, and Chair of the Department of Pharmacology, Feinberg School of Medicine; Director for the Center for Pharmacogenomics

Dimitri Krainc, M.D., Ph.D., Aaron Montgomery Ward Professor of Neurology, and Chair of the Department of Neurology, Feinberg School of Medicine; Director for the Center for Rare and Neurological Diseases

Leonidas Platanias, M.D., Ph.D., Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology, Feinberg School of Medicine; Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Richard B. Silverman, Ph.D., Patrick G. Ryan/Aon Professor of Chemistry and Professor of Molecular Biosciences, Weinberg College of Arts and Sciences

Douglas E. Vaughan, M.D., Irving S. Cutter Professor of Medicine- Cardiology, Feinberg School of Medicine; Chair, Department of Medicine